Ken Miyoshi
Impact in
- Dermatology top 5%
- Dermatology and Skin Diseases
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- Psoriasis: Treatment and Pathogenesis 3
-
- Cancer and Skin Lesions 2
- Dermatologic Treatments and Research 1
- Dermatology and Skin Diseases 1
- Co-authors
- Shigetoshi Sano (4 shared papers)Mikiro Takaishi (3 shared papers)John DiGiovanni (3 shared papers)Masahito Tarutani (3 shared papers)Kimiko Nakajima (3 shared papers)Mitsunori Ikeda (2 shared papers)Naoki Asao (1 shared paper)Takashi Kanda (1 shared paper)
- Journals
- The Journal of Immunology (2 papers)The Journal of Dermatology (2 papers)Journal of Dermatological Science (1 paper)Dermatology (1 paper)Journal of Investigative Dermatology (1 paper)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Ken Miyoshi
8 papers receiving 369 citations
Peers
Comparison fields: 5 of 64
- Dermatology 138
- Immunology 256
- Oncology 119
- Toxicology 13
- Pathology and Forensic Medicine 39
Countries citing papers authored by Ken Miyoshi
This map shows the geographic impact of Ken Miyoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Miyoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Miyoshi more than expected).
Fields of papers citing papers by Ken Miyoshi
This network shows the impact of papers produced by Ken Miyoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Miyoshi. The network helps show where Ken Miyoshi may publish in the future.
Co-authors
The 22 scholars most cited alongside Ken Miyoshi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 202 | |
| 2 | 2011 | 138 | |
| 3 | 2002 | 17 | |
| 4 | 2010 | 8 | |
| 5 | 2002 | 4 | |
| 6 | 1997 | 4 | |
| 7 | 1995 | 1 | |
| 8 | 2011 | 1 |
About Ken Miyoshi
Ken Miyoshi is a scholar working on Immunology, Dermatology, Oncology, Molecular Biology and Surgery, having authored 8 papers that have together received 375 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Cancer and Skin Lesions (2 papers), Autoimmune Bullous Skin Diseases (1 paper), Dermatologic Treatments and Research (1 paper), Teratomas and Epidermoid Cysts (1 paper), Dermatology and Skin Diseases (1 paper) and Natural product bioactivities and synthesis (1 paper). The work is most often cited by research in Dermatology (138 citations), Immunology (256 citations), Oncology (119 citations), Toxicology (13 citations) and Pathology and Forensic Medicine (39 citations). Ken Miyoshi has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Shigetoshi Sano, Mikiro Takaishi, John DiGiovanni, Masahito Tarutani, Kimiko Nakajima, Mitsunori Ikeda, Naoki Asao, Takashi Kanda, Tatsuo Iiyama and Hideki Nakajima. Their work appears in journals such as The Journal of Immunology, The Journal of Dermatology, Journal of Dermatological Science, Dermatology and Journal of Investigative Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.